Yahoo Search Busca da Web

Resultado da Busca

  1. 4 de fev. de 2024 · Kenneth C. Frazier and Joseph Y. Bae to join governing board. Kenneth C. Frazier, J.D. ’78, and Joseph Y. Bae ’94 will join the Harvard Corporation as its two newest members, the University announced Sunday. An acclaimed leader, distinguished lawyer, experienced board member, and noted advocate for economic inclusion and opportunity ...

  2. 4 de mai. de 2024 · Kenneth F. Frazier Obituary. It is always difficult saying goodbye to someone we love and cherish. Family and friends must say goodbye to their beloved Kenneth F. Frazier of Columbus, Indiana, who passed away at the age of 82, on April 17, 2024. You can send your sympathy in the guestbook provided and share it with the family.

  3. 4 de fev. de 2021 · 4 February 2021. Reuters. The US is losing one of its few black leaders at the top of a major American company. Merck & Co's chief executive Kenneth Frazier is retiring at the end of June, the ...

  4. 26 de out. de 2022 · He will succeed Kenneth C. Frazier, who plans to retire on Nov. 30, 2022, after a long-tenured career at Merck that began in 1992. Frazier led the company for 10 years as president and chief executive officer, from 2011 through 2021. He has served as a Merck director since January 2011 and chairman of its board of directors since December 2011.

  5. 1 de jul. de 2011 · The new CEO of pharmaceutical giant Merck, Kenneth Frazier ’78 is driven by high hopes for the company and what it can do. In March, a New York Times front-page story cataloged the woes besetting the pharmaceutical industry, including losses of billions of dollars from expiring patents, a dearth of promising new drugs, pressure to reduce prices, and layoffs in research and development.

  6. 9 de nov. de 2023 · He is Kenneth Frazier, former CEO of Merck, who held that job for 10 years before retiring in 2021 and joining General Catalyst. Here’s the story he told about his first year on the job: “I ...

  7. Kenneth C. Frazier is the Executive Chairman of Merck’s board of directors, a role he began in July 2021, following his retirement from a decade-long tenure as Merck’s President and Chief Executive Officer. Under Frazier's leadership, Merck delivered innovative life-saving medicines and vaccines as well as long-term and sustainable value to ...